Pharmaceutical
Indications

 

37 Results were found on Technologies

Leading Researchers:

Quinone-based small molecules as a novel therapy for Alzheimer's disease and Amyloidosis

The TechnologyDisease modifying drugs for Alzheimer's disease (AD) and the related Mild Cognitive Impairment (MCI), based on rationally-designed quinone-based small molecules. Results so far resulted in significant reversal of AD symptoms while... Read More >

Leading Researchers:

Procollagen C-Proteinase Enhancer 1 (PCPE-1) as a Biomarker for Fibrosis relating to the diagnosis of fibrotic diseases based on total PCPE in serum

Collaboration with Dr Shlomit Mesilaty, Dr Yair Anikster, Prof Ido Wolf Metabolic Enzymatic Laboratory, Sheba Medical Center. Bone metastasis is a major clinical concern that can cause severe pain, bone fractures, spinal cord... Read More >

Leading Researchers:

METHODS AND KITS FOR DETERMINING PREDISPOSITION TO DEVELOP KIDNEY DISEASES

Many rare kidney disorders exhibit a monogenic, Mendelian pattern of inheritance. Population-based genetic studies have identified many genetic variants associated with an increased risk of developing common kidney diseases. Strongly associated... Read More >

Leading Researchers:

Silver-enzyme hybrids for the treatment bacterial and fungal biofilms in chronic wounds, burns and surgical wounds

TechnologyThe silver-enzyme hybrid cream is a formulation consisting of soluble, single glucose oxidase molecules coated with thin (~1.5nm) metallic silver coating. This formulation will penetrate into mixed microbial biofilms and affect... Read More >

Immunotherapy for Stroke and Cognition in a Cerebral Amyloid Angiopathy Animal Model

Cerebrovascular dysfunction is a fundamental part of the pathology of several neurodegenerative diseases and rated as one of the most prominent cause for dementia. Cerebral amyloid angiopathy (CAA) results in intra-parenchymal and subarachnoid... Read More >

Leading Researchers:

Oral Mucosa-derived Stem Cells: A Unique Population for the Prevention and Treatment of Ischemic Heart Failure

The Technology A novel pluripotent stem cell population, termed hOMSCs, has been isolated from adult human oral mucosa. The hOMSC population expresses markers of pluripotent embryonic stem cells and of multipotent mesenchymal stem cell markers... Read More >

Optimization of Myocardial Tissue Repair and Regeneration with Iron-oxide Nanoparticles Formulated in Macrophage-Targeted Carriers

The Technology A novel approach for the treatment of AMI has been developed using IONPs. IONPs, when injected into the infarcted myocardium, lead to improved heart function after MI. IONPs activate anti-inflammatory macrophages and... Read More >

Leading Researchers:

EG30 for the treatment of Alzheimer's disease

EG-30: clinical phase drug for AMD and Glaucoma EG-30 – the highlights: · Excellent safety profile in healthy volunteers and glaucoma... Read More >

Leading Researchers:

Hemostatic Soft Tissue Adhesives

Novel bio-adhesives based on the natural polymers, gelatin (protein) and alginate (polysaccharide), and a carbodiimide crosslinking agent. The carbodiimide crosslinking agent is much less toxic than other crosslinking agents used in bioadhesives... Read More >

Leading Researchers:

BiPS for the treatment of Diabetes

Additional information can be provided upon request. Read More >